Loading data
SRZNNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.48 m USD | 10.66 m USD | 0 USD | — | — |
| Research and development expense | 29.37 m USD | 21.13 m USD | 27.23 m USD | 37.01 m USD | 40.18 m USD |
| Operating profit | -42.09 m USD | -25.54 m USD | -45.78 m USD | -44.34 m USD | -54.39 m USD |
| Profit before tax | -242.03 m USD | -63.56 m USD | — | — | — |
| Income tax expense | 0 USD | — | — | — | — |
| Net income (reported basis) | -242 m USD | -64 m USD | -43.04 m USD | -36 m USD | -54.6 m USD |
| Basic earnings per share | -32.37 USD/share | -21.67 USD/share | -21.33 USD/share | -15.56 USD/share | -2.21 USD/share |
| Diluted earnings per share | -32.37 USD/share | -21.67 USD/share | -21.33 USD/share | -15.56 USD/share | -2.21 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.